APA

Lee D., Xu I. M., Chiu D. K., Lai R. K., Tse A. P., Lan Li L., Law C., Tsang F. H., Wei L. L., Chan C. Y., Wong C., Ng I. O. & Wong C. C. (20170911). Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. : The Journal of clinical investigation.

Chicago

Lee Derek, Xu Iris Ming-Jing, Chiu David Kung-Chun, Lai Robin Kit-Ho, Tse Aki Pui-Wah, Lan Li Lynna, Law Cheuk-Ting, Tsang Felice Ho-Ching, Wei Larry Lai, Chan Cerise Yuen-Ki, Wong Chun-Ming, Ng Irene Oi-Lin and Wong Carmen Chak-Lui. 20170911. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. : The Journal of clinical investigation.

Harvard

Lee D., Xu I. M., Chiu D. K., Lai R. K., Tse A. P., Lan Li L., Law C., Tsang F. H., Wei L. L., Chan C. Y., Wong C., Ng I. O. and Wong C. C. (20170911). Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. : The Journal of clinical investigation.

MLA

Lee Derek, Xu Iris Ming-Jing, Chiu David Kung-Chun, Lai Robin Kit-Ho, Tse Aki Pui-Wah, Lan Li Lynna, Law Cheuk-Ting, Tsang Felice Ho-Ching, Wei Larry Lai, Chan Cerise Yuen-Ki, Wong Chun-Ming, Ng Irene Oi-Lin and Wong Carmen Chak-Lui. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. : The Journal of clinical investigation. 20170911.